Salaries and Expenses
Schedules
TAFS: 015-0200 2021/2022 - Salaries and Expenses
| Line # | Split | Description | Iteration 1 Previously Approved Amount | Iteration 2 OMB Action Amount | Footnotes |
|---|---|---|---|---|---|
| 1000 | DA | Discretionary Unob Bal: Brought forward, October 1 (Direct, Actual) | Line added— | +$110,180,180 $110,180,180 | See footnotes below |
| Footnotes for line 1000 (DA) (Current): | B1: Difference in estimate and actual Direct unobliagated balances primarily attributed to Q4 successful procurement actions relating to aircraft proceeds and COVID-19 & NICS Supplement funding. | ||||
| 1000 | DE | Discretionary Unob Bal: Brought forward, October 1 (Direct, Estimate) | $180,649,273 | -$180,649,273 $0 | |
| 1000 | RA | Reimbursable Unob Bal: Brought forward, October 1 (Reimb, Actual) | Line added— | +$13,733,533 $13,733,533 | See footnotes below |
| Footnotes for line 1000 (RA) (Current): | B2: Difference in estimate and actual Reimbursable unobliagated balances primarily attributed to Q4 successful procurement actions relating to agreements received from Intel Community partners. | ||||
| 1000 | RE | Reimbursable Unob Bal: Brought forward, October 1 (Reimb, Estimate) | $46,300,000 | -$46,300,000 $0 | |
| 1060 | D | Unob Bal: Antic nonexpenditure transfers (net) | $500,000 | $500,000 | |
| 1061 | D | Unob Bal: Antic recov of prior year unpaid obl (Direct) | $22,350,000 | $22,350,000 | |
| 1061 | R | Unob Bal: Antic recov of prior year unpaid obl (Reimb) | $4,500,000 | $4,500,000 | |
| 1740 | D | BA: Disc: Spending auth:Antic colls, reimbs, other | $2,501,000 | $2,501,000 | |
| 1740 | R | BA: Disc: Spending auth:Antic colls, reimbs, other | $0 | $0 | |
| 1920 | Total budgetary resources avail (disc. and mand.) | $256,800,273 | -$103,035,560 $153,764,713 | ||
| 6001 | Category A -- 1st quarter | $78,209,821 | -$45,407,276 $32,802,545 | ||
| 6002 | Category A -- 2nd quarter | $1,500,000 | $1,500,000 | ||
| 6012 | Category B -- Health Care Fraud Abuse and Control | $6,824,452 | -$2,162,901 $4,661,551 | ||
| 6013 | Category B -- CJIS and COVID-19 Funding | $170,266,000 | -$55,465,383 $114,800,617 | ||
| 6190 | Total budgetary resources available | $256,800,273 | -$103,035,560 $153,764,713 | ||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| B1 | Difference in estimate and actual Direct unobliagated balances primarily attributed to Q4 successful procurement actions relating to aircraft proceeds and COVID-19 & NICS Supplement funding. |
| B2 | Difference in estimate and actual Reimbursable unobliagated balances primarily attributed to Q4 successful procurement actions relating to agreements received from Intel Community partners. |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
No footnotes available.
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.